These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Advanced APMs and the emerging role of immuno-oncology agents: balancing innovation and value. Seiden MV; Neubauer M; Verrilli D Am J Manag Care; 2017 Feb; 23(2 Spec No.):SP69-SP77. PubMed ID: 28298130 [No Abstract] [Full Text] [Related]
6. The 2018 Nobel Prize in medicine goes to cancer immunotherapy (editorial for BMC cancer). Guo ZS BMC Cancer; 2018 Nov; 18(1):1086. PubMed ID: 30415640 [No Abstract] [Full Text] [Related]
7. Customer pyramid framework for CAR T-cell therapies in immuno-oncology. Malik NN; Durdy MB Drug Discov Today; 2016 Oct; 21(10):1563-1565. PubMed ID: 27640934 [No Abstract] [Full Text] [Related]
9. "Tumor immunology meets oncology (TIMO) XV", April 25th-27th 2019, Halle/Saale, Germany. Steven A; Massa C; Seliger B Cancer Immunol Immunother; 2020 May; 69(5):901-909. PubMed ID: 32025850 [TBL] [Abstract][Full Text] [Related]
10. "Tumor immunology meets oncology" (TIMO) XI, May 22-23, 2015, Halle/Saale, Germany. Quandt D; Seliger B Cancer Immunol Immunother; 2016 May; 65(5):625-30. PubMed ID: 27060001 [No Abstract] [Full Text] [Related]
11. From bench to community oncology clinic: the promise of immunotherapy. Chandra S Am J Manag Care; 2017 Feb; 23(2 Spec No.):SP57-SP58. PubMed ID: 28298135 [No Abstract] [Full Text] [Related]
12. Fifteenth Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT) on Cancer Bio-Immunotherapy, Siena, Italy, October 5-7, 2017. Maio M; Lofiego MF; Fazio C; Cannito S; Chiarucci C; Giacobini G; Valente M; Tunici P; Covre A; Russo V Cancer Immunol Immunother; 2019 Jan; 68(1):151-158. PubMed ID: 30094463 [No Abstract] [Full Text] [Related]
13. The global landscape of cancer cell therapy. Tang J; Hubbard-Lucey VM; Pearce L; O'Donnell-Tormey J; Shalabi A Nat Rev Drug Discov; 2018 Jul; 17(7):465-466. PubMed ID: 29795477 [No Abstract] [Full Text] [Related]
14. A power surge for cancer immunotherapy: antibodies, vaccines, and engineered T cells fuel new optimism. Nelson B Cancer Cytopathol; 2014 Jan; 122(1):1-2. PubMed ID: 24424750 [No Abstract] [Full Text] [Related]
15. Recent Advances in Cancer Immunotherapy. Suda K Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33672298 [TBL] [Abstract][Full Text] [Related]
16. Models for Immuno-oncology Research. Cancer Cell; 2020 Aug; 38(2):145-147. PubMed ID: 32781038 [TBL] [Abstract][Full Text] [Related]
17. Managing patient expectations with immuno-oncology. Dangi-Garimella S Am J Manag Care; 2017 Feb; 23(2 Spec No.):SP59. PubMed ID: 28298136 [No Abstract] [Full Text] [Related]
18. From New directions in immuno-oncology. Romero D Nat Rev Clin Oncol; 2019 Nov; 16(11):660. PubMed ID: 31541198 [No Abstract] [Full Text] [Related]
19. Immunotherapy of Cancer: Developments and Reference Points, an Unorthodox Approach. Nikolaou M; Nikolaou G; Digklia A; Pontas C; Tsoukalas N; Kyrgias G; Tolia M Integr Cancer Ther; 2019; 18():1534735419827090. PubMed ID: 30791740 [TBL] [Abstract][Full Text] [Related]
20. CAR-T cells: the next era in immuno-oncology. Feinberg BA; Fillman J; Simoncini J; Nabhan C Am J Manag Care; 2017 Feb; 23(2 Spec No.):SP48-SP52. PubMed ID: 28298134 [No Abstract] [Full Text] [Related] [Next] [New Search]